Molecular targeted therapy: A new avenue in glioblastoma treatment (Review)-Reference-Cited by-同舟云学术

Molecular targeted therapy: A new avenue in glioblastoma treatment (Review)

Published:2022-12-15 Issue:2 Volume:25 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

El Atat Oula¹,Naser Rayan¹,Abdelkhalek Maya¹,Habib Ralph¹,El Sibai Mirvat¹

Affiliation:

1. Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, Beirut 1102 2801, Lebanon

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference359 articles.

1. Glioblastoma multiforme: A review of its epidemiology and pathogenesis through clinical presentation and treatment;Hanif;Asian Pac J Cancer Prev,2017

2. Temozolomide for immunomodulation in the treatment of glioblastoma;Karachi;Neuro Oncol,2018

3. Survival in glioblastoma: A review on the impact of treatment modalities;Delgado-López;Clin Transl Oncol,2016

4. Epidemiology and outcome of glioblastoma;Tamimi,2017

5. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1;Verhaak;Cancer Cell,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brachytherapy is an effective and safe salvage option for re-irradiation in recurrent glioblastoma (rGBM): A systematic review;Radiotherapy and Oncology;2024-01

2. Fibronectin Type III Domain Containing 3B as a Potential Prognostic and Therapeutic Biomarker for Glioblastoma;Biomedicines;2023-11-28

3. Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies;Journal of Experimental & Clinical Cancer Research;2023-09-21

4. Rhizochalinin Exhibits Anticancer Activity and Synergizes with EGFR Inhibitors in Glioblastoma In Vitro Models;Molecular Pharmaceutics;2023-09-21

5. Molecular landscapes of glioblastoma cell lines revealed a group of patients that do not benefit from WWOX tumor suppressor expression;Frontiers in Neuroscience;2023-09-15